In vitro effects of antipsychotics on mitochondrial respiration
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Assessment of drug-induced mitochondrial dysfunctions is important in drug development as well as in the understanding of molecular mechanism of therapeutic or adverse effects of drugs. The aim of this study was to investigate the effects of three typical antipsychotics (APs) and seven atypical APs on mitochondrial bioenergetics. The effects of selected APs on citrate synthase, electron transport chain complexes (ETC), and mitochondrial complex I- or complex II-linked respiratory rate were measured using mitochondria isolated from pig brain. Complex I activity was decreased by chlorpromazine, haloperidol, zotepine, aripiprazole, quetiapine, risperidone, and clozapine. Complex II + III was significantly inhibited by zotepine, aripiprazole, quetiapine, and risperidone. Complex IV was inhibited by zotepine, chlorpromazine, and levomepromazine. Mitochondrial respiratory rate was significantly inhibited by all tested APs, except for olanzapine. Typical APs did not exhibit greater efficacy in altering mitochondrial function compared to atypical APs except for complex I inhibition by chlorpromazine and haloperidol. A comparison of the effects of APs on individual respiratory complexes and on the overall mitochondrial respiration has shown that mitochondrial functions may not fully reflect the disruption of complexes of ETC, which indicates AP-induced modulation of other mitochondrial proteins. Due to the complicated processes associated with mitochondrial activity, it is necessary t…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Leucht, S., Cipriani, A., Spineli, L., Mavridis, D., Örey, D., Richter, F., Samara, M., Barbui, C., Engel, R. R., Geddes, J. R., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60733-3 · Cited by 2,561
Srere, P. A. (1969) · Methods in Enzymology · doi:10.1016/0076-6879(69)13005-0 · Cited by 2,005
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61764-x · Cited by 1,930
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
Structures of Metal Sites of Oxidized Bovine Heart Cytochrome c Oxidase at 2.8 Å
Tsukihara, T., Aoyama, H., Yamashita, E., Tomizaki, T., Yamaguchi, H., Shinzawa-Itoh, K., Nakashima, R., Yaono, R., & Yoshikawa, S. (1995) · Science · doi:10.1126/science.7652554 · Cited by 1,415
Complete Structure of the 11-Subunit Bovine Mitochondrial Cytochrome bc 1 Complex
Iwata, S., Lee, J. W., Okada, K., Lee, J. K., Iwata, M., Rasmussen, B., Link, T. A., Ramaswamy, S., & Jap, B. K. (1998) · Science · doi:10.1126/science.281.5373.64 · Cited by 1,253
Biochemical and molecular investigations in respiratory chain deficiencies
Rustin, P., Chretien, D., Bourgeron, T., Gérard, B., Rötig, A., Saudubray, J. M., & Munnich, A. (1994) · Clinica Chimica Acta · doi:10.1016/0009-8981(94)90055-8 · Cited by 1,243
Cytochrome oxidase: an endogenous metabolic marker for neuronal activity
Wong-Riley, M. T. T. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90165-3 · Cited by 1,238
Cited by
Biological hypotheses, risk factors, and biomarkers of schizophrenia
Fišar, Z. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110626 · Cited by 111
Self-citationMitochondrial dysfunction as a critical event in the pathophysiology of bipolar disorder
Scaini, G., Andrews, T., Lima, C. N. D. C., Benevenuto, D., STRECK, E. L., & Quevedo, J. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.12.002 · Cited by 93
Das, S. C., Hjelm, B. E., Rollins, B. L., Sequeira, A., Morgan, L., Omidsalar, A. A., Schatzberg, A. F., Barchas, J. D., Lee, F. S., Myers, R., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02127-1 · Cited by 57
“The decreased DLPFC complex I activity in the presence of medications agrees with previous in-vitro and rodent model reports showing decreased complex I activity induced by antipsychotics [59, 60].”
ResultMitochondrial Dysfunction in Cardiac Diseases and Therapeutic Strategies
Huang, Y., & Zhou, B. (2023) · Biomedicines · doi:10.3390/biomedicines11051500 · Cited by 45
Second-generation antipsychotics and metabolic syndrome: a role for mitochondria
Mortimer, K. R. H., Katshu, M. Z. U. H., & Chakrabarti, L. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1257460 · Cited by 52
“One study found a range of antipsychotics inhibited respiration through specific complexes (65).”
BackgroundZhou, Y., Zou, J., Xu, J. B., Zhou, Y., Cen, X., & Zhao, Y. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115219 · Cited by 45
Drug-induced mitochondrial toxicity: Risks of developing glucose handling impairments
Kuretu, A., Arineitwe, C., Mothibe, M. E., Ngubane, P. S., Khathi, A., & Sibiya, N. H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1123928 · Cited by 33
“These agents have been used since the 1950s for psychotic disorders such as mood disorders and schizophrenia with the development of chlorpromazine as the first anti-psychotic (5, 6, 78).”
BackgroundLarrea, A., Sánchez-Sánchez, L., Díez-Martín, E., Elexpe, A., Torrecilla, M., Astigarraga, E., & Barreda‐Gómez, G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061727 · Cited by 34
“Various antidepressants and mood stabilizers can inhibit different components of the mETC [24,25], increasing ROS production and reducing antioxidant capacity [26].”
BackgroundEffect of Novel Antipsychotics on Energy Metabolism — In Vitro Study in Pig Brain Mitochondria
Ľupták, M., Fišar, Z., & Hroudová, J. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02498-4 · Cited by 24
Self-citationIn vitro effects of antidepressants and mood-stabilizing drugs on cell energy metabolism
Cikánková, T., Fišar, Z., & Hroudová, J. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01791-3 · Cited by 24
“Effects of drugs used for treatment of schizophrenia and acute mania (mGPCR antagonists) were described in our previous studies (Cikankova et al. 2019; Hroudova and Fisar 2012).”
MethodSelf-citationMihai, D. P., Ungurianu, A., Ciotu, C. I., Fischer, M. J. M., Olaru, O. T., Nițulescu, G. M., Andrei, C., Zbârcea, C. E., Zanfirescu, A., Șeremet, O. C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137183 · Cited by 22
“Mice that received cuprizone and risperidone showed an apparent decrease in mitochondrial thiol content, which is in line with previous reports detailing its detrimental effects on the mitochondria [54,55].”
ResultHardy, R. E., Chung, I., Yu, Y., Loh, S. H. Y., Morone, N., Soleilhavoup, C., Travaglio, M., Serreli, R., Panman, L., Cain, K., et al. (2023) · Biology Direct · doi:10.1186/s13062-023-00375-9 · Cited by 22
“Whilst our findings are contrary to previous reports that detected inhibition of the ETC by a wider range of antipsychotic compounds, the earlier studies were limited to cell-free purified mitochondrial systems [49, 50].”
ResultGiménez‐Palomo, A., Guitart‐Mampel, M., Meseguer, A., Borràs, R., García‐García, F. J., Tobías, E., Valls‐Roca, L., Alsina‐Restoy, X., Roqué, G., Sánchez, E., et al. (2023) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13635 · Cited by 22
Kucera, J., Horská, K., Hruška, P., Kuruczová, D., Micale, V., Kučerová, J., & Vašků, J. B. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110165 · Cited by 16
Tseng, H.-C., Wang, M., Fang, C.-H., Lin, Y.-W., & Soung, H.-S. (2023) · Brain Sciences · doi:10.3390/brainsci13071064 · Cited by 14
“The reciprocal interaction between mitochondria and NMDA receptors amplifies the state of nitrative and oxidative stress provoked by HP. Additionally, under pathological conditions associated with increased production of ROS and RNS, nitric oxide (NO) inhibits crucial enzymes involved in energy metabolism and becomes…”
BackgroundLinking Hypothermia and Altered Metabolism with TrkB Activation
Alitalo, O., González-Hernández, G., Rosenholm, M., Kohtala, P., Matsui, N., Müller, H. K., Theilmann, W., Klein, A. B., Kärkkäinen, O. K., Rozov, S. V., et al. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00350 · Cited by 11
Effects of psychoactive drugs on cellular bioenergetic pathways
Bortolasci, C. C., Spolding, B., Kidnapillai, S., Richardson, M. F., Vasilijevic, N., Martin, S. D., Gray, L. J., McGee, S. L., Berk, M., & Walder, K. R. (2020) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2020.1755450 · Cited by 14
Fišar, Z., Ľupták, M., & Hroudová, J. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.07.015 · Cited by 13
Self-citationRisperidone Toxicity on Human Blood Lymphocytes in Nano molar Concentrations
Yousefsani, B. S., Salimi, A., Imani, F., Ramezani, M., Shirani, K., Seydi, E., & Pourahmad, J. (2022) · Drug Research · doi:10.1055/a-1830-8701 · Cited by 10
Risk Assessment of Psychotropic Drugs on Mitochondrial Function Using In Vitro Assays
Rosell-Hidalgo, A., Eakins, J. A., Walker, P., Moore, A. L., & Ghafourian, T. (2023) · Biomedicines · doi:10.3390/biomedicines11123272 · Cited by 10
“This was supported by spectrophotometric measurements of enzymatic activities for aripiprazole and quetiapine which showed strong inhibition of CI and partial inhibition of CII + III [51].”
BackgroundInfluentialChen, S., Wang, M., Chang, K.-C., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810206 · Cited by 9
Swain, C. A., Robbs, E. J., Verma, L., Brandt, H., Seppaenen, A. L., & Cavnar, P. J. (2025) · PLoS ONE · doi:10.1371/journal.pone.0318878 · Cited by 8
Kramar, B., Marolt, T. P., Yılmaz, A. M., Šuput, D., Milisav, I., & Monsalve, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011119 · Cited by 9
Hsu, C.-P., Tseng, H.-C., Fang, C.-H., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125458 · Cited by 6
Marolt, T. P., Kramar, B., Vovk, A., Podgornik, H., Šuput, D., & Milisav, I. (2023) · Antioxidants · doi:10.3390/antiox12111930 · Cited by 6
“On the other hand, OLA did not affect mitochondrial respiration, while ARI inhibited respiratory complexes in mitochondria from pig brains [19].”
BackgroundAssessment of the Effects of Drugs on Mitochondrial Respiration
Hroudová, J., & Fišar, Z. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1270-5_9 · Cited by 6
Self-citationAdvanced Drug Delivery Technologies for Enhancing Bioavailability and Efficacy of Risperidone
Rathi, R., Mehetre, N. M., Goyal, S., Singh, I., Huanbutta, K., & Sangnim, T. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s492684 · Cited by 10
Xiong, Z., Wang, H., Qu, Y., Peng, S., He, Y., Yang, Q., Xu, X., Lv, D., Liu, Y., Xie, C., et al. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110831 · Cited by 5
Elexpe, A., Sánchez-Sánchez, L., Tolentino‐Cortez, T., Astigarraga, E., Torrecilla, M., & Barreda‐Gómez, G. (2022) · Biomedicines · doi:10.3390/biomedicines10050980 · Cited by 4
“Regarding the pathologic effects of Alzheimer’s disease, ligands for sigma 1 and 2 receptors can regulate the CNS immune response and modulate amyloid-beta production [35,50].”
BackgroundMultilevel evidence of MECP2-associated mitochondrial dysfunction and its therapeutic implications
Balicza, P., Gézsi, A., Fedor, M., Sági, J. C., Gál, A., Varga, N. Á., & Molnár, M. J. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1301272 · Cited by 3
Groenewald, A., Burns, K. E., Tingle, M. D., Ward, M., & Power, A. (2025) · Toxicology Reports · doi:10.1016/j.toxrep.2025.101990 · Cited by 6
Mitrović, M. M., Marković, B. S., Rosic, G. L., Ristic, M., Jovicic, N. U., Jurišić, V., Milosavljević, J., Matić, S., Ljujić, B., & Selaković, D. (2026) · Biomedicines · doi:10.3390/biomedicines14020315 · Cited by 2
Arjmand, A., Javan, E. A., Shahraki, J., Shaboustani, R., Seydi, E., & Pourahmad, J. (2023) · Pharmaceutical Sciences · doi:10.34172/ps.2023.12 · Cited by 2
Fiore, M., Saltarelli, S., Mastro, L. D., D’Ambrosio, E., Ianniello, A., Bertolino, A., Pergola, G., Favia, M., & Rampino, A. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110814 · Cited by 3
Wang, Y., Wu, H. N., Geng, R., Wang, C., Lv, Q., Li, Z., & Yi, Z. (2025) · ALPHA PSYCHIATRY · doi:10.31083/ap49352 · Cited by 1
“Studies have suggested that genes within the TMEM family can modulate insulin signaling and lipid metabolism, which may contribute to their protective effects in metabolic regulation [28–30].”
Ngamratanapaiboon, S. (2021) · Research Square · doi:10.21203/rs.3.rs-776559/v1 · Cited by 1
Hardy, R. E., Chung, I., Yu, Y., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.02.535223 · Cited by 1
Kramar, B., Marolt, T. P., Yılmaz, A. M., Šuput, D., Milisav, I., & Monsalve, M. (2024) · Preprints.org · doi:10.20944/preprints202407.0129.v1 · Cited by 1
Mitochondrial abnormalities in psychological disorders
Mousavi, T., & Abdollahi, M. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822416-8.00013-0
Ngoh, S. H., & Gudi, A. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-07905-5
“However, much of this evidence arises from preclinical studies, primarily in animal models [34, 35], and translational applicability to human subjects remains an area requiring further exploration.”
Škutová, K., Fišar, Z., & Hroudová, J. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111749 · Cited by 2
Self-citationEnergetic dysregulations in psychotic disorders: Targets for new therapeutics
Anderson, J., Sonntag, K., Le, T. D. V., Shannon, K., Wang, C., Du, F., Chen, X., McPhie, D. L., Öngür, D., Cohen, B. M., et al. (2026) · FEBS Journal · doi:10.1111/febs.70719
Metadata
- Authors
- Cikánková, T., Fišar, Z., Bakhouche, Y., Ľupták, M., & Hroudová, J.
- Affiliations
- Charles University (CZ)
- Corresponding author
- Hroudová, Jana
- Venue
- Naunyn-Schmiedeberg's Archives of Pharmacology
- Published
- 2019-05-19
- Volume
- 392
- Issue
- 10
- Pages
- 1209-1223
- ISSN
- 0028-1298 (ISSN-L)
- 1432-1912
- OpenAlex
- W2946350621
- Semantic Scholar
- a9ba236d950fe067d3b1439656645ad01097910b
- Cited by
- 44
- References
- 75
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 8 · 2023: 12 · 2022: 4 · 2021: 6 · 2020: 3 · 2019: 1
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Naunyn-Schmiedeberg s Archives of Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Grantová Agentura České Republiky (17-07585Y)
- Grantová Agentura, Univerzita Karlova (34119)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- antipsychotic drugs, mitochondrial respiration, mitochondrial dysfunction, respiratory chain complexes, mitochondrial complex I inhibition, complex II inhibition, complex IV inhibition, chlorpromazine, haloperidol, zotepine, aripiprazole, quetiapine, risperidone, clozapine, olanzapine, drug-induced mitochondrial toxicity, citrate synthase
- MeSH terms
- Animals, Brain, Energy Metabolism, Mitochondria, Swine, Antipsychotic Agents, Electron Transport Complex II, Electron Transport Complex I, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.